Trial
NCT01475253
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Allergan
Collaborators
TARIS Biomedical, Inc.
Condition
Interstitial Cystitis
Intervention
Lidocaine Releasing Intravesical System - LiRIS®
Why stopped
This study was not enrolled completely and was terminated.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-09-21